These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38159083)

  • 21. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the prevalence of uveitis between Crohn's disease and ulcerative colitis: A systematic review and meta-analysis.
    Lin H; Zhang J; Liang C; Wu D; Tan Y; Luo L; Liu Z
    Acta Ophthalmol; 2024 Jun; 102(4):e485-e492. PubMed ID: 37830172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.
    Alinaghi F; Tekin HG; Burisch J; Wu JJ; Thyssen JP; Egeberg A
    J Crohns Colitis; 2020 Mar; 14(3):351-360. PubMed ID: 31504363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
    Jayasooriya N; Baillie S; Blackwell J; Bottle A; Petersen I; Creese H; Saxena S; Pollok RC;
    Aliment Pharmacol Ther; 2023 Mar; 57(6):635-652. PubMed ID: 36627691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of inflammatory bowel disease in South America: A systematic review.
    Selvaratnam S; Gullino S; Shim L; Lee E; Lee A; Paramsothy S; Leong RW
    World J Gastroenterol; 2019 Dec; 25(47):6866-6875. PubMed ID: 31885427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil.
    Cassol OS; Zabot GP; Saad-Hossne R; Padoin A
    World J Gastroenterol; 2022 Aug; 28(30):4174-4181. PubMed ID: 36157112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prevalence of Adherent-Invasive
    Kamali Dolatabadi R; Feizi A; Halaji M; Fazeli H; Adibi P
    Front Med (Lausanne); 2021; 8():730243. PubMed ID: 34926490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Dai C; Wang YN; Tian WN; Huang YH; Jiang M
    Int Immunopharmacol; 2022 Nov; 112():109269. PubMed ID: 36182873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ
    Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA.
    Singer D; Thompson-Leduc P; Gupta D; Cheng WY; Poston S; Ma S; Pawlowski JE; Duh MS; Morris ED; Devine F; Farraye FA
    Gastroenterol Rep (Oxf); 2023; 11():goad016. PubMed ID: 37064550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
    Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
    J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, Australia.
    Bhatia R; Yeoh SW; Vaz K; Studd C; Wilson J; Bell S; Otahal P; Venn A
    Intern Med J; 2019 May; 49(5):622-630. PubMed ID: 30230160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
    Khalaji A; Babajani N; Amirsardari Z; Saeedian B; Peiman S; Berger NA; Behnoush AH
    Inflamm Bowel Dis; 2024 Apr; 30(4):629-640. PubMed ID: 37669127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia.
    Studd C; Cameron G; Beswick L; Knight R; Hair C; McNeil J; Desmond P; Wilson J; Connell W; Bell S
    J Gastroenterol Hepatol; 2016 Jan; 31(1):81-6. PubMed ID: 26222770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study.
    Agrawal M; Christensen HS; Bøgsted M; Colombel JF; Jess T; Allin KH
    Gastroenterology; 2022 Dec; 163(6):1547-1554.e5. PubMed ID: 35952799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].
    Saro Gismera C; Riestra Menéndez S; Milla Crespo A; Sánchez Fernández R; Lacort Fernández M; Argüelles Fernández G; Chovac Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
    An Med Interna; 2003 Jan; 20(1):3-9. PubMed ID: 12666301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.